BRAF V600E
Oncology·MeSH: Colorectal Neoplasms
7 drugs in development·5 companies·2 clinical trials
Drug Pipeline by Phase
Approved(3)
Phase 3(1)
| Drug | Company |
|---|---|
| Encorafenib | IGM Biosciences, Inc. (IGMS) |
Phase 1(2)
Unknown(1)
| Drug | Company |
|---|---|
| tafinlar/mekinist | Novartis AG (NVS) |
Compare drugs
Frequently asked questions
How many drugs are in development for BRAF V600E?
BioSniper tracks 7 drugs in development for BRAF V600E across 5 companies.
How many clinical trials target BRAF V600E?
There are 2 clinical trials targeting BRAF V600E tracked by BioSniper.
Deep-dive into BRAF V600E
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis